EP1487542 - USE OF ASC-1 INHIBITORS TO TREAT NEUROLOGICAL AND PSYCHIATRIC DISORDERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.06.2007 Database last updated on 22.01.2025 | Most recent event Tooltip | 15.06.2007 | Application deemed to be withdrawn | published on 18.07.2007 [2007/29] | Applicant(s) | For all designated states H. Lundbeck A/S Ottiliavej 9 2500 Valby-Copenhagen / DK | [N/P] |
Former [2004/52] | For all designated states H. Lundbeck A/S Ottiliavej 9 2500 Valby-Copenhagen / DK | Inventor(s) | 01 /
THOMSEN, Christian Kystvejen 321 DK-4671 Stroby / DK | 02 /
HELBOE, Lone Roarsvej 17, 4tv DK-2000 Frederiksberg / DK | 03 /
EGEBJERG, JENSEN, Jan Jens Munks Vej 24 DK-8200 Arhus N / DK | [2004/52] | Representative(s) | Kjerrumgaard, Lars Bo, et al H. Lundbeck A/S, Ottiliavej 9 2500 Valby-Copenhagen / DK | [N/P] |
Former [2004/52] | Kjerrumgaard, Lars Bo, et al H. Lundbeck A/S, Ottiliavej 9 2500 Valby-Copenhagen / DK | Application number, filing date | 03744313.2 | 12.03.2003 | [2004/52] | WO2003DK00154 | Priority number, date | DK20020000417 | 15.03.2002 Original published format: DK 200200417 | US20020365070P | 15.03.2002 Original published format: US 365070 P | [2004/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03077998 | Date: | 25.09.2003 | Language: | EN | [2003/39] | Type: | A1 Application with search report | No.: | EP1487542 | Date: | 22.12.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.09.2003 takes the place of the publication of the European patent application. | [2004/52] | Search report(s) | International search report - published on: | SE | 25.09.2003 | Classification | IPC: | A61P25/08, A61K31/198, A61K31/4172, // C07K14:47 | [2004/52] | CPC: |
G01N33/502 (EP,US);
A61K31/198 (EP,US);
A61K31/4172 (EP,US);
A61P25/00 (EP);
A61P25/08 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P43/00 (EP);
C07K14/47 (EP,US);
G01N33/5008 (EP,US);
G01N33/5058 (EP,US);
G01N33/5076 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2004/52] | Extension states | AL | 15.10.2004 | LT | 15.10.2004 | LV | 15.10.2004 | MK | 15.10.2004 | Title | German: | VERWENDUNG VON ASC-1-HEMMERN ZUR BEHANDLUNG VON NEUROLOGISCHEN UND PSYCHIATRISCHEN ERKRANKUNGEN | [2004/52] | English: | USE OF ASC-1 INHIBITORS TO TREAT NEUROLOGICAL AND PSYCHIATRIC DISORDERS | [2004/52] | French: | UTILISATION DES INHIBITEURS ASC-1 DANS LE TRAITEMENT DES TROUBLES NEUROLOGIQUES ET PSYCHIATRIQUES | [2004/52] | Entry into regional phase | 15.10.2004 | National basic fee paid | 15.10.2004 | Designation fee(s) paid | 15.10.2004 | Examination fee paid | Examination procedure | 01.10.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 15.10.2004 | Examination requested [2004/52] | 22.04.2005 | Despatch of a communication from the examining division (Time limit: M08) | 10.04.2006 | Reply to a communication from the examining division | 06.07.2006 | Despatch of a communication from the examining division (Time limit: M06) | 17.01.2007 | Application deemed to be withdrawn, date of legal effect [2007/29] | 27.02.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/29] | Request for further processing for: | 10.04.2006 | Request for further processing filed | 10.04.2006 | Full payment received (date of receipt of payment) Request granted | 28.04.2006 | Decision despatched | Fees paid | Renewal fee | 31.03.2005 | Renewal fee patent year 03 | 31.03.2006 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.03.2007 | 05   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0158944 (JAPAN SCIENCE & TECH CORP [JP], et al); | [X]WO0108676 (JAVITT DANIEL C [US]); | [X]US3892852 (JOULLIE MAURICE, et al); | [X]US4416898 (LE FUR GERARD R [FR]); | [X]US2002002146 (HALEVIE-GOLDMAN BRIAN D [US]); | [X]WO9952519 (GEN HOSPITAL CORP [US]); | [X]US4837219 (HUTTERER JEFFREY [US]); | [X]EP0387867 (SEARLE & CO [US]); | [X] - FUKASAWA Y. ET AL, "Identification and characterization of a Na+-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (20000331), vol. 275, no. 13, pages 9690 - 9698, XP002235447 DOI: http://dx.doi.org/10.1074/jbc.275.13.9690 | [X] - NAKAUCHI J. ET AL, "Cloning and characterization of a human brain Na+-independent transporter for small neutral amino acids that transports D-serine with high affinity", NEUROSCIENCE LETTERS, (2000), vol. 287, pages 231 - 235, XP001146487 DOI: http://dx.doi.org/10.1016/S0304-3940(00)01169-1 | [X] - MATSUO H. ET AL, "Mouse Asc-1 (asc-type amino acid transporter 1) maps to chromosome 7, region B1-B5", CHROMOSOME RESEARCH, (2000), vol. 8, page 456, XP002968794 | [X] - THOMSEN C. ET AL, "Characterisation of a D-serine transporter and functional modulation of NMDA receptors", SOCIETY FOR NEUROSCIENCE, (2001), vol. 27, XP002968795 | [X] - MATSUO H. ET AL, "Cloning, functional characterization and localization of ASC-1; A high affinity amino acid transporter for D-serine", SOCIETY FOR NEUROSCIENCE, (2001), vol. 27, XP002968796 |